hotspot -WSS

hotspot

author：entertainment 2025-09-28 15:57:04 - browse：34

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Driven by the pandemic, applicants flood public health schools

WSS

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Vir antibody drug aimed at influenza A fails in clinical trial

Ask STAT: What do you want to know about ChatGPT in medicine?

With FDA staff opposed to Sarepta therapy, top official intervened

Disclosing genetic information: not as worrisome as once feared

Vir antibody drug aimed at influenza A fails in clinical trial

hotspot

hotspot

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC concerned about possible undetected monkeypox spread in U.K.

Anesthesiologist group: stop taking Ozempic before surgery

The story of mRNA: From a loose idea to a tool that may help curb Covid

The cancer drug shortage isn’t new — and neither are the solutions

Vir antibody drug aimed at influenza A fails in clinical trial

How one medical school became remarkably diverse

Winning ticket for $1 billion Powerball jackpot sold in California

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Do masks work? RCTs can't tell us

hotspot

7 more heat

DeSantis talks Trump, trans issues and 'what wokeness is'

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Divers poised to search for children washed away in Pennsylvania flash flood

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

In areas with more Black doctors, Black people live longer

Wikipedia

hotspot

focus

knowledge